Bright Capital leads Series A round for FloDesign Sonics

FloDesign Sonics has received $10 million in Series A funding. Bright Capital led the round with participation from investors that included Ventry Industries. Based in Wilbraham, Mass., FloDesign Sonics is a provider of acoustic separation technology.

VC-backed Zafgen nabs $20 mln from Oxford and MidCap Financial

Zafgen has secured a $20 million loan from Oxford and MidCap Financial. Based in Cambridge, Mass., Zafgen is a biopharmaceutical company focused on treating severely obese patients. Zafgen’s investors include RA Capital Management, Brookside Capital, Venrock and Alta Partners.

Provista Diagnostics attracts $6 mln

Provista Diagnostics has received $6 million in Series B funding. The investors were not named. Based in Scottsdale, Ariz., Provista is a developer of diagnostic, prognostic and predictive tests for cancers affecting women.

Australian veterinary drug developer Nexvet racks up $31.5 mln

Nexvet Biopharma has closed $31.5 million in Series B financing. Investors included Farallon Capital Management, Adage Capital Partners, Foresite Capital and Tavistock Life Sciences subsidiary fund Boxer Capital. Based in Melbourne, Australia, Nexvet is a veterinary biologic drug developer.

Serena Capital and Matrix Partners back Work4

Work4 said Thursday that it has secured $7 million in Series B funding. The investors were Serena Capital and Matrix Partners. In addition to the funding, Xavier Lorphelin, managing partner at Serena Capital, will join Work4′s board of directors. Based in San Francisco and Paris, Work4 is a social and mobile recruiting firm.

Irish biotech firm Heart Metabolics snags $20 mln Series A funds

Heart Metabolics said Thursday that it has closed $20 million in Series A funding. The investors were venBio, Seroba Kernel Life Sciences, Brandon Capital Partners (on behalf of AustralianSuper) and AshHill. Based in Dublin, Ireland, Heart Metabolics is a biotech firm focused on developing treatments for cardio-metabolic diseases.

Austin-based M87 nets $3 mln

M87 has secured $3 million in funding. The investors included 21 Vianet and Qualcomm Ventures, the VC arm of Qualcomm Inc. Based in Austin, M87 is a wireless network infrastructure software firm.

PEHUB Community

Join the 12494 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget